News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Daily News “Tranquilizadores” Resultados a 18 Meses con el AVB Absorb Aunque Todavía Necesitamos Seguimientos Más Largos Michael O'Riordan August 01, 2016
News Daily News ‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed Michael O'Riordan August 01, 2016
News Conference News EuroPCR 2016 Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining Michael O'Riordan May 17, 2016
News Daily News Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse Michael O'Riordan February 23, 2016
News Daily News Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated Michael O'Riordan February 23, 2016
News Conference News TCT 2013 ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR October 30, 2013
News Conference News ESC 2013 Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients Caitlin E. Cox September 02, 2013
News Daily News Adaptive Responses to Radiation Exposure in Cath Labs May Protect Physicians L.A. McKeown August 26, 2011
News Industry News St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System April 29, 2011